Estrogen effects in the heart

Molecular and Cellular Biochemistry

Volumn 160-161, Issue , 1996, Pages 307-313

  Pelzer, T ^a   Shamim, A ^a   Neyses, L ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cardiac hypertrophy; Estrogens; Gene expression; Genetic program; Hypertension; Myocardium; Signal transduction

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; LIPOPROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASOACTIVE AGENT;

ARTICLE; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; HEART; HEART DISEASE; HEART MUSCLE; HORMONAL REGULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; POSTMENOPAUSE; PROTEIN DNA INTERACTION; SEX DIFFERENCE;

ANIMALS; CARDIOMEGALY; CONNEXIN 43; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; HEART; HUMANS; HYPERTENSION; MODELS, BIOLOGICAL; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 0029814631     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00240064     Document Type: Article

References (64)

1. Glendy RE, Levine SA, White PD: Coronary disease in youth: Comparison of 100 patients under 40 with 300 persons past 80. JAMA 109: 1775-1781, 1937
2. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH: Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 325: 756-762, 1991
3. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM: Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program follow-up study. Circulation 75: 1102-1109, 1987
4. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE: Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 69: 176-178, 1992
5. Adams MR, Clarkson TB, Kaplan JR, Koritnik DR: Ovarian secretions and artheriosclerosis. In: JN Gutmann, AH DeCherney, PM Sarrel, (eds). Ovarian secretions and cardiovascular and neurological function. Raven Press, New York, 1990
6. Klein-Hitpass L, Schorpp M, Wagner W, Ryffel GU: An estrogen responsive element derived from the 5′ flanking region of the xenopus vitellogenin A12 gene functions in transfected human cells. Cell 46: 1053-1061, 1986
7. Walter P, Green S, Krust A, Bornert JM, Jeltsch JM, Staub A, Jensen E, Scrace G, Waterfield M, Chambon P: Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA 82: 7889-7893, 1985
8. Kumar V, Green S, Staub A, Chambon P: Localisation of the estradiol-binding and putative DNA-binding domains of the human estrogen receptor. EMBO J 5: 2231-2236, 1986
9. Waterman ML, Stuart A, Nelson C, Greene GL, Evans RM, Rosenfeld MG: A single domain of the estrogen receptor confers deoxyribonucleic acid binding and transcriptional activation of the rat prolactin gene. Mol Endocrinol 2: 14-21, 1988
10. Migliaccio A, Di Domenico M, Green S, de Falco A, Kajtaniac EL, Blasi F, Chambon P, Auricchio F: Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding. Mol Endocrinol 3: 1061-1069, 1988
11. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491-1494, 1995
12. Jacq X, Brou C, Lutz Y, Davidson I, Chambon P, Tora L: Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79: 107-117, 1994
13. Kato S, Sasaki H, Suzawa M, Masushige S, Tora L, Chambon P, Gronemeyer H: Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol Cell Biol 15: 5858-5867, 1995
14. Gaub MP, Bellard M, Scheuer I, Chambon P, Sassone-Corsi P: Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell 63: 1267-1276, 1990
15. Alroy I, Towers TL, Freedman LP: Transcriptional repression of the interleukin-II gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15: 5789-5799, 1995
16. Sukovich DA, Mukherjee R, Benfield PA: A novel, cell-type-specific mechanism for estrogen receptor mediated gene activation in the absence of an estrogen-responsive element. Mol Cell Biol 14: 7134-7143, 1994
17. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O: Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90: 11162-11166, 1993
18. MacKenzie J: Irritation of the sexual apparatus. Am J Med Sci 87: 360, 1884
19. Ueland K, Parer JT: Effects of estrogens on the cardiovascular system of the ewe. Am J Obstet Gynecol 96: 400, 1966
20. Silva de Sa MF, Meirelles RS: Vasodilatation effect of estrogen on the human umbilical artery. Gynecol Invest 8: 307, 1977
21. Horwitz KB, Horwitz LD: Canine vascular tissues are targets for androgens, estrogens, progestins and glucocorticoids. J Clin Invest 69: 750, 1982
22. Karas RH, Patterson BL, Mendelsohn ME: Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 98: 1943-1950, 1994
23. Hishikawa K, Nakaki K, Marumo T, Suzuki H, Kato R, Saruta T: Upregulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 360: 291-293, 1995
24. Rhee CY, Spaet TH, Stemerman MB, Lajam F, Shiang HH: Estrogen suppression of surgically induced vascular intima hyperplasia in rabbits. J Lab Clin Med 90: 77, 1977
25. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW: Estradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 109: 612-617, 1993
26. Grohé C, Briesemeister G, Stimpel L, Karas RH, Vetter H, Neyses L: Functional estrogen receptors in myocardial and myogenic cells. Circulation 90: I-538, 1994
27. Morano I, Gagelmann M, Arner A, Ganten U, Ruegg JC: Myosin isoenzymes of vascular smooth and cardiac muscle in the spontaneously hypertensive and normotensive male and female rat: A comparative study. Circ Res 59: 456-462, 1986
28. Malhotra A, Buttrick P, Scheuer J: Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol 259: H866-H871, 1990
29. Morano I, Gerstner J, Rüegg JC, Ganten U: Regulation of myosin heavy chain expression in the hearts of hypertensive rats by testosterone. Circ Res 66: 1585-1590, 1990
30. Neyses L, Pelzer T: The biological cascade leading to hypertrophy. Eur Heart J 16 (suppl. N): 8-11, 1996
31. Neyses, Nouskas J, Luycken J, Fronhoffs S, Oberdorf S, Williams RS, Sukhatme VP, Vetter H: Induction of immediate-early genes by angiotensin-11 and endothelin- 1 in adult rat cardiomyocytes. J Hypertens 11: 927-934, 1993
32. Dubik D, Dembinski TC, Shiu RPC: Stimulation of the c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res 47: 6517-6521, 1987
33. Weisz A, Rosales R: Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res 18: 5097-5106, 1990
34. Cicatiello L, Sica V, Bresciani F, Weisz A: Identification of a specific pattern of 'immediate-early' gene activation induced by estrogen during mitogenic stimulation of rat uterine cells. Receptor 3: 17-30, 1993
35. Neyses L, Nouskas J, Vetter H: Inhibition of endothelin- 1 induced myocardial protein synthesis by an antisense oligonucleotide against the early growth response gene- 1. Biochem Biophys Res Commun 181: 22-27, 1991
36. Thayer MJ, Tapscott SJ, Davis RL, Wright WE, Lassar AB, Weintraub H: Positive autoregulation of the myogenic determination gene myoD1. Cell 58: 241-248, 1989
37. Beyer EC, Paul DL, Goodenough DA: The connexin family of gap junction proteins. J Membrane Biol 116: 187-194, 1990
38. Willecke K, Hennemann H, Dahl E, Jungbluth S, Heynkes R: The diversity of connexin genes encoding gap junctional proteins. Eur J Cell Biol 56: 1-7, 1991
39. De Leon JR, Buttrick PM, Fishman GL: Functional analysis of the connexin-43 gene promoter in vivo and in vitro. J Mol Cell Cardiol 26: 379-389, 1994
40. Yu W, Dahl G, Werner R: The connexin-43 gene is responsive to estrogen. Proc R Soc Lond 255: 125-132, 1994
41. Bastide B, Neyses L, Ganten D, Paul M, Willecke K, Traub O: The gap junction protein connexin-40 is preferentially expressed in vascular endothelium as well as conductive bundles of rat myocardium and is increased under hypertensive conditions. Circ Res 73: 1138-1149, 1993
42. Weiner C, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S: Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci 91: 5212-5216, 1994
43. Proudler AJ, Ahmed Al H, Crook D, Fogelman I, Rymer JM, Stevenson JC: Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet 346: 89-90, 1995
44. Testut P, Soubrier F, Corvol P, Hubert C: Functional analysis of the human somatic angiotensin-I converting enzyme gene promoter. Biochem J 293: 843-848, 1993
45. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO: Acute vascular effects of estrogen in postmenopausal women. Circulation 90: 786-791, 1994
46. Brass LM, Kisiel D, Sarrel PM: A correlation between estrogen and middle cerebral artery blood velocity at different times of the menstrual cycle in women with catamenial migraines. J Cardiovasc Technol 9: 68, 1990
47. Williams JK, Adams MR, Klopfenstein HS: Estrogen modulates responses of atherosclerotic coronary arteries. Circ Res 81: 1680-1687, 1990
48. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P: Endothelium-independent relaxation of rabbit coronary artery by 17β-estradiol in vitro. Br J Pharmacol 104: 1033-1037, 1991
49. Van Buren G, Yang D, Clark KE: Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 16: 828-833, 1992
50. 2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 106: 739-745, 1992
51. 2+ release induced by thromboxane in porcine coronary artery. Circulation 91: 2619-2626, 1995
52. White RE, Darkow DJ, Falvo Lang JL: Estrogen relaxes coronary arteries by opening BkCa channels through a cGMP-dependent mechanism. Circ Res 77: 936-942, 1995
53. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 240: 889-895, 1988
54. Beato M, Herrlich P, Schütz G: Steroid hormone receptors: Many actors in search for a plot. Cell 83: 851-857, 1995
55. Xie QW, Cho H, Calaycay J, Murnford R, Swiderek KM, Lee TB, Ding A, Troso T, Nathan C: Cloning and characterization of inducible nitric oxide synthase from mouse macrophage. Science 256: 225-228, 1992
56. Xie QW, Whisnant R, Nathan C: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers iriducibility by interferon-gamms and bacterial lipopolysaccharides. J Exp Med 177: 1779-1784, 1993
57. Chang WC, Nakao J, Orimo H, Murota SI: Stimulation of prostaglandin cyclooxygenase and prostacyclin synthase activities by estradiol in rat aortic smooth muscle cells. Biochem Biophys Acta 620: 472, 1980
58. Katzenellenbogen BS, Nardulli AM, Read LD: Estrogen regulation of proliferation and hormonal modulation of estrogen and progesterone receptor biosynthesis and degradation in target cells. Prog Clin Biol Res 322: 201-211, 1990
59. Cembran J, Lillo M, Val J, Mardones J: Influence of sex difference and hormones on elastin and collagen in aorta of chickens. Circ Res 8: 527, 1960
60. Kenney NJ, Saeki T, Gottardis M, Kim N, Garcia-Morales P, Martin MB, Normanno M, Ciardiello F, Day A, Butler ML, Salomon DS: Expression of transforming growth factor α antisense mRNA inhibits the estrogen-induced production of TGFα and estrogen-induced proliferation of estrogen-responsive human breast cancer cells. J Cell Physiol 156: 497-514, 1993
61. Pottratz ST, Bellido T, Mocharia H, Crabb D, Manolagas SC: 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism J Clin Invest 93: 944-950, 1994
62. Michels KM, Lee WH, Seltzer A, Saavedra JM, Bondy CA: Up-regulation of pituitary [125] insulin-like growth factor-I (IGF-I) binding and IGF-I binding protein-2 and IGF-I gene expression by estrogen. Endocrinology 132: 23-29, 1993
63. Fuqua SAW, Blum-Saringos M, McGuire WL: Induction of the estrogen-regulated '24K' protein by heat shock. Cancer Res 49: 4126, 1984
64. Mendelsohn ME, Zhu Y, O'Neill S: The 29-kDa proteins phosphorylated in thrombin-activated platelets are forms of the estrogen receptor-related 27 kDa heat shock protein. Proc Natl Acad Sci USA 88: 11212-11216, 1991